Sergi Ferré obtained his MD degree from the School of Medicine of the Central University of Barcelona and his PhD degree from the School of Medicine of the Autonomous University of Barcelona. Early in his career, Dr. Ferré reported the existence of specific interactions between adenosine A2A and dopamine D2 receptors which may provide a new therapeutic approach for the treatment of Parkinson’s disease and other neuropsychiatric disorders. Dr. Ferré’s subsequent experimental work at the National Institute on Drug Abuse has led to important conceptual advances in the field of G protein-coupled receptor pharmacology. Adenosine continues to be a focus of Dr. Ferré’s research which includes the numerous social and clinical implications of the widespread caffeine use.

 

Journal of Caffeine Research is an international multidisciplinary peer-reviewed journal, and it addresses the need for an authoritative source on caffeine science and its effects on human health. Starting in January 2018, under its new title as Journal of Caffeine and Adenosine Research, the Journal will expand its scope to cover innovative pharmacological advances in adenosine research. The Journal will be the only peer-reviewed publication to publish a broad range of human and animal studies including basic and translational research on adenosine; and clinical, behavioral, pharmacological research on caffeine.

 

Dr. Ferré will be supported by an outstanding team of Associate Editors including Yijuang Chern, PhD, Academia Sinica; Francisco Ciruela, PhD, Universitat de Barcelona; Ana Maria Sebastião, PhD, Universidade de Lisboa; Patrizia Popoli, MD, PhD, Istituto Superiore di Sanità; David Blum, PhD, Institut National de la Santé et de la Recherche Médicale; George Hasko, PhD, Rutgers New Jersey Medical School; and Laura Juliano, PhD, American University.

 

“It’s an honor to be taking over as Editor-in-Chief,” says Dr. Ferré. “We want to transform this Journal into the leading publication on adenosine as well as caffeine research.”

 

For information on manuscript submission, please visit Journal of Caffeine Research website.

 

About the Journal
Journal of Caffeine Research covers the effects of caffeine on a wide range of diseases and conditions, including mood disorders, neurological disorders, cognitive performance, cardiovascular disease, and sports performance. Journal of Caffeine Research explores all aspects of caffeine science including the biochemistry of caffeine; its actions on the human body; benefits, dangers, and contraindications; and caffeine addiction and withdrawal, across all stages of the human life span from prenatal exposure to end-of-life. The Journal will be retitled to Journal of Caffeine and Adenosine Research in January 2018. Complete information is available on the Journal of Caffeine Research website.

 

About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Cannabis and Cannabinoid Research, The Journal of Alternative and Complementary Medicine, and Journal of Child and Adolescent Psychopharmacology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.